Technology

Technology: Innovating Wound Care with BioHeal Hydrogel

At BIOHEAL THERAPEUTICS, we are committed to advancing wound care solutions with our innovative BioHeal Hydrogel, developed using BioHeal Matrix Technology (BMT). This solubilized amnion membrane technology is designed to provide and alternative to traditional amnion-based products and support improved wound care practices globally.

Who Can Benefit from BioHeal Hydrogel?

BioHeal Hydrogel is intended to address challenges associated with hard-to-heal injuries, including chronic wounds and severe burns. While not available in the United States, this technology is developed with the needs of patients and healthcare systems in mind. The prevalence of chronic wounds underscores the need for innovative solutions:  Here’s a look at the scope of the problem:

• Approximately 37.3 million Americans have diabetes, with a significant subset at risk for diabetic foot ulcers.
• Over 5.2 million adults suffer from chronic wounds annually, many of which are classified as difficult to heal.
• Severe burns and abrasions impact over 1 million people in the U.S. each year.

Those conditions contribute to substantial healthcare costs globally, with advanced wound care materials comprising a meaningful portion of these expenses.

The Science Behind BioHeal Matrix Technology (BMT)

BioHeal Matrix Technology (BMT) leverages solubilized amnion membranes to create a hydrogel designed to maintain the biological properties of amnion while offering ease of application. This innovative approach supports the natural wound healing process by:

• Creating a moisture-retaining barrier conducive to wound repair.
• Integrating hyaluronic acid to support angiogenesis and cell proliferation.
• Avoiding immune rejection by maintaining non-immunogenic properties.

Key Features of BioHeal Hydrogel

• Ease of Use: Designed for efficient preparation and application without the need for sutures or staples.
• Moisture Retention: Helps maintain an optimal healing environment by preventing wound drying.
• Non-Stick Application: Absorbs into the wound bed without adherence, reducing disruption during dressing changes.
• Storage-Friendly: Stable at room temperature for convenient transportation and storage.

Research and Development

BioHeal Hydrogel is supported by preclinical studies conducted by researchers, including work and Wake Forest Institute for Regenerative Medicine (WFIRM). These studies have investigated the use of solubilized amnion hydrogels for wound management, with finding suggesting their potential to promote wound closure and integration with surrounding tissues.

Please note: Specific claims about the efficacy of BioHeal Hydrogel are based on laboratory and preclinical studies, and additional research is ongoing to further explore its applications.

Global Reach and Committment

BIOHEAL THERAPEUTICS holds 12 global patents (issued or pending) for its solubilized amnion membrane (SAM) portfolio, covering the U.S., Canada, Europe, Australia, Japan, and South Korea. Initial funding for this technology was provided by the U.S. Department of Defense for use in treating treating severe burns and wounds in military applications.

Our collaboration with the Wake Forest Institute for Regenerative Medicine (WFIRM) ensures that BioHeal Hydrogel represents the forefront of amnion and hyaluronic acid technology.

Transforming Wound Care Worldwide

At BIOHEAL THERAPEUTICS, we are dedicated to delivering innovative wound care solutions to improve outcomes for patients and clinicians globally. While BioHeal Hydrogel is not available in the United States, it represents our to advancing regenerative medicine and addressing the challenges of wound care.

For more information, contact us today to learn how BioHeal Hydrogel can support wound care innovation.